Asian press release distribution

Press Releases for Friday, June 18, 2021

Leon Fuat Berhad Shareholders Pass Resolution to Acquire Factory for Rm28.0 Million 18:00 HKT/SGT

IMC Ventures Partners with PIER71 to Invest and Nurture the Maritime and Supply Chain Ecosystem in Singapore 17:00 HKT/SGT

Toyota Yaris WRC to face another 'new' challenge on Africa's return 16:08 HKT/SGT

三菱パワー、木質系バイオマスから製造した持続可能な代替航空燃料を定期便に供給 16:00 HKT/SGT

三菱重工、公式Twitterが認証バッジ獲得 16:00 HKT/SGT

Hitachi to Donate to COVID-19 Relief Efforts in India and Other Countries 15:19 HKT/SGT

Eisai, Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai's MORAb-202 Antibody Drug Conjugate 14:02 HKT/SGT

馬來西亞允許了來自中國的新冠肺炎測試劑盒以供為緊急使用；Holista Colltech 收到 15,000 單位的初始訂單 14:00 HKT/SGT

Malaysia Diberikan Kebenaran Untuk Kit Uji COVID-19 dari China Bagi Tujuan Penggunaan Kecemasan; Syarikat Tempatan Holista Colltech Menerima Pesanan Awal Sebanyak 15,000 Unit Untuk Penggunaan 14:00 HKT/SGT

马来西亚允许了来自中国的新冠肺炎测试剂盒以供为紧急使用；Holista Colltech 收到 15,000 单位的初始订单 14:00 HKT/SGT

Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment 14:00 HKT/SGT

Mitsubishi Power Ships JAC Gas Turbine to Brazil: Marlim Azul Project Will Be the Most Fuel-efficient Gas Turbine Power Plant in South America 13:07 HKT/SGT

Alpha DX Sets Sights on China with Proposed Investment in JobForesight 13:00 HKT/SGT

科济药业正式登陆港交所产品管线多元化成长潜力巨大 12:36 HKT/SGT

科濟藥業正式登陸港交所產品管線多元化成長潛力巨大 12:35 HKT/SGT

三菱商事、「緊急事態宣言」の解除を受けた対策について 11:00 HKT/SGT

エーザイとブリストルマイヤーズスクイブ、エーザイ創製の抗体薬物複合体MORAb-202に関するグローバルな戦略的提携契約を締結 09:00 HKT/SGT

Woven Capital、フリート事業のデジタル・トランスフォメーションを手掛ける米国Ridecell社に出資 08:00 HKT/SGT

ACN Search:

CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575